Insights On Trial Design

  1. Navigating The Global Epilepsy Clinical Trial Terrain In 2024 6/3/2024

    Explore the forefront of epilepsy research with Novotech CRO's comprehensive analysis, unveiling innovative therapies, clinical trials, and future trends shaping epilepsy care.

  2. Why In The World Should You Come To San Diego? 4/19/2024

    With over 180 sessions across 13 tracks and nine engaging learning formats, attendees will delve into emerging fields such as precision medicine, regulatory CMC, and product quality, and value-based access.

  3. Mental Health: 5 Facts About Psychedelics 10/16/2024

    As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.

  4. High Density, Low Availability: Rethinking Ophthalmic Trial Readiness 4/16/2025

    The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.

  5. How Pharmaceutical Companies Can Effectively Engage With PAOs 2/11/2025

    Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.

  6. Regulatory Opportunities For Decentralized Clinical Trials 5/13/2025

    Project SHASTA, a pioneering effort to measure the benefits of decentralized trial elements, reveals significant regulatory opportunities that could shape the future of clinical research.

  7. Living With An Invisible Disease: One Woman's Journey With CF 4/22/2025

    Meet a clinical research participant who has spent her life navigating the challenges of cystic fibrosis, leading her to become an advocate, amplifying the voices of others facing similar struggles.

  8. A Framework For Improving Maternity Healthcare In The US (And Elsewhere) 5/14/2025

    The U.S. has the highest maternal mortality rate among industrialized nations. For Black women, the odds are even worse. Here's why — and what can be done.

  9. EDC Powers End-To-End Data Management In Pharma-Sponsored Trials 9/4/2025

    As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.

  10. Cell And Gene Therapy Field Quiet In Q2 8/15/2024

    While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.